Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02888171 · ClinicalTrials.gov registry record · NA

Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency

A NA study of Chronic Kidney Disease and Anemia, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT02888171 is a NA study of Chronic Kidney Disease and Anemia that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 60 participants, below the 3,206-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02888171, a NA study of Chronic Kidney Disease and Anemia, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The main objective of the study is to compare the impact of oral ferric citrate compared to standard of care oral ferrous sulfate on serum iron, percent transferrin saturation, ferritin, hepcidin and hemoglobin levels in individuals with moderate to severe chronic kidney disease (CKD) and absolute iron deficiency.

Interventions

  • DRUG ferric citrate
  • DRUG ferrous sulfate

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2016-09
Est. Completion 2019-03-30
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT02888171

The ClinicalTrials.gov registry entry for NCT02888171 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,206-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (98% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Chronic Kidney Disease appearing as the primary indexed condition, and to 2 interventions - of which ferric citrate is the first listed.

NCT02888171 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT02888171 about?

NCT02888171 is a clinical study titled "Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency". The main objective of the study is to compare the impact of oral ferric citrate compared to standard of care oral ferrous sulfate on serum iron, percent transferrin saturation, ferritin, hepcidin and hemoglobin levels in individuals with moderate to severe chronic kidney disease (CKD) and absolute i...

What is the current status of trial NCT02888171?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2016-09. Estimated completion is 2019-03-30.

What conditions does trial NCT02888171 study?

This clinical trial studies the following conditions: Chronic Kidney Disease, Anemia, Iron-deficiency.

What interventions are being tested in trial NCT02888171?

The interventions under investigation include: ferric citrate (DRUG), ferrous sulfate (DRUG).

Who is sponsoring clinical trial NCT02888171?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02888171 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Kidney Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.